Clin2
NCT07064005Possibly a fitRecruiting

Boosting glutathione with a supplement in Parkinson's

Parkinsons Disease (PD)

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether a supplement called gamma-glutamylcysteine can increase levels of a natural antioxidant called glutathione in the brain of people with Parkinson's. If you are between 50 and 80 and have mild cognitive symptoms, this trial may help researchers understand a new way to support brain health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
50 years to 80 years
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of Parkinson's disease.
  • You are between 50 and 80 years old.
  • You are able to read and write in English.
  • You do not have any metal implants (like a pacemaker or ear implants) and are not claustrophobic.
  • You have not had cancer, active psychosis, severe kidney or liver problems, or a past traumatic head injury.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07583251Recruiting· Phase 1
Safety of a supplement for mild memory loss

This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.

Pittsburgh, Pennsylvania
NCT04740580Recruiting· Early Phase 1
Test glutathione for brain inflammation in Alzheimer’s

This early-stage study tests whether taking glutathione can affect brain “inflammation” and metabolism in people with Alzheimer’s disease. You might benefit from a new treatment approach, while helping researchers understand what works best for early Alzheimer’s-related brain changes.

Houston, Texas
NCT07703137Enrolling by invitation
NAD Supplement for Parkinson's Disease Study

This study tests whether a supplement called NAD (a natural substance that helps cells produce energy) can improve symptoms in people with Parkinson's disease. You would take the supplement daily for several weeks, and researchers will check your movement, thinking, and overall well-being.

Oklahoma City, Oklahoma
NCT05266417Recruiting· Phase 2
Nasal insulin plus glutathione for Parkinson’s symptoms

This Phase 2 study tests whether adding nasal insulin and glutathione can improve Parkinson’s disease symptoms and function. You would use study medicine through the nose while keeping your other treatments mostly the same during the trial.

Davie, Florida
NCT07592767Not yet recruiting· Phase 2
Resveratrol supplement for Parkinson's disease

This study tests whether a supplement called resveratrol (found naturally in grapes and berries) can help slow or improve Parkinson's disease symptoms. You'll take resveratrol pills or a placebo while researchers monitor your memory, movement, and overall health.

NCT05241262Recruiting· Phase 1
N-acetylcysteine for people with m.3243A>G and low brain glutathione

This trial tests whether the supplement N-acetylcysteine (NAC) can help people who have the m.3243A>G mitochondrial genetic change and low levels of a brain chemical called glutathione. The study aims to see if raising glutathione in the brain is safe and potentially beneficial for these patients.

New York, New York

Hear when a new Parkinsons Disease (PD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.